These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

23992 related items for PubMed ID: 16245793

  • 1. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 4. [Recent progress in mycobacteriology].
    Okada M, Kobayashi K.
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [Abstract] [Full Text] [Related]

  • 5. [Non-tuberculous mycobacteriosis. What has been coming out].
    Kajiki A.
    Kekkaku; 2011 Feb; 86(2):113-25. PubMed ID: 21404655
    [Abstract] [Full Text] [Related]

  • 6. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [Abstract] [Full Text] [Related]

  • 7. [Up-to-date understanding of tuberculosis immunity].
    Mitsuyama M, Akagawa K, Kobayashi K, Sugawara I, Kawakami K, Yamamoto S, Okada Z.
    Kekkaku; 2003 Jan; 78(1):51-5. PubMed ID: 12683337
    [Abstract] [Full Text] [Related]

  • 8. [Anti-tuberculosis immunity by cytotoxic T cells * granulysin and the development of novel vaccines (HSP-65 DNA+IL-12 DNA)].
    Okada M, Kita Y.
    Kekkaku; 2010 Jun; 85(6):531-8. PubMed ID: 20662249
    [Abstract] [Full Text] [Related]

  • 9. [Exogenous re-infection in tuberculosis].
    Tsuchiya T.
    Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009
    [Abstract] [Full Text] [Related]

  • 10. [New era in molecular epidemiology of tuberculosis in Japan].
    Takashima T, Iwamoto T.
    Kekkaku; 2006 Nov; 81(11):693-707. PubMed ID: 17154049
    [Abstract] [Full Text] [Related]

  • 11. [Future prospects of molecular epidemiology in tuberculosis].
    Matsumoto T, Iwamoto T.
    Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
    [Abstract] [Full Text] [Related]

  • 12. Toll-like receptors in innate immunity.
    Takeda K, Akira S.
    Int Immunol; 2005 Jan; 17(1):1-14. PubMed ID: 15585605
    [Abstract] [Full Text] [Related]

  • 13. [Evolution of IGRA researches].
    Ariga H, Harada N.
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [Abstract] [Full Text] [Related]

  • 14. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K, Sano C.
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M, Nakajima Y.
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [Abstract] [Full Text] [Related]

  • 16. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis.
    Reiling N, Ehlers S, Hölscher C.
    Immunol Lett; 2008 Feb 15; 116(1):15-23. PubMed ID: 18191460
    [Abstract] [Full Text] [Related]

  • 17. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs.
    Jo EK.
    Curr Opin Infect Dis; 2008 Jun 15; 21(3):279-86. PubMed ID: 18448973
    [Abstract] [Full Text] [Related]

  • 18. [Protective immunity against Mycobacterium tuberculosis].
    Kawamura I.
    Kekkaku; 2006 Nov 15; 81(11):687-91. PubMed ID: 17154048
    [Abstract] [Full Text] [Related]

  • 19. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis.
    Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ.
    J Immunol; 1999 Oct 01; 163(7):3920-7. PubMed ID: 10490993
    [Abstract] [Full Text] [Related]

  • 20. Novel prophylactic and therapeutic vaccine against tuberculosis.
    Okada M, Kita Y, Nakajima T, Kanamaru N, Hashimoto S, Nagasawa T, Kaneda Y, Yoshida S, Nishida Y, Nakatani H, Takao K, Kishigami C, Inoue Y, Matsumoto M, McMurray DN, Dela Cruz EC, Tan EV, Abalos RM, Burgos JA, Saunderson P, Sakatani M.
    Vaccine; 2009 May 26; 27(25-26):3267-70. PubMed ID: 19200841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 1200.